At the same time, EBNA1 can promote the degradation of Smad2 protein and inhibit the transcription of TGF-β target gene protein tyrosine phosphatase receptor κ (PTPRK), thereby promoting the growth and survival of Hodgkin lymphoma (HL) cells [57]. Here, SMAD2 is linked to Hodgkins lymphoma.